Search

Neil S Cooch

from Oreland, PA
Age ~48
Get Report
Also known as:
Neil Stuart Cooch, Neil F Cooch
Related to:
Sachiko Cooch, 54Christopher P Cooch, 43John E Cooch, 78Maralyn Cooch, 72
Connected to:
Steven L Cooch, 65Steven M Coodin, 50Vittal Cooduvalli, 54Adicia D Coody, 43Danielle E Coody, 45Denis L Coody, 45Jacob M Coody, 39Johnny C Coody, 83Joyce K Coody, 76Latia Coody, 38

Neil Cooch Phones & Addresses

  • Oreland, PA
  • Chalfont, PA
  • Los Angeles, CA
  • Laverock, PA
  • Flourtown, PA
  • 525 Filbert Rd, Oreland, PA 19075 (215) 233-1427

Resumes

Resumes

Neil Cooch Photo 1

Research Associate And Lab Manager At The Wistar Institute

View page
Position:
Research Associate and Lab Manager at The Wistar Institute
Location:
Greater Philadelphia Area
Industry:
Pharmaceuticals
Work:
The Wistar Institute - Philadelphia, PA since Aug 2012
Research Associate and Lab Manager
Fujirebio Diagnostics, Inc. - Malvern, Pa Jun 2012 - Jul 2012
GMP Lab Technician in Serum Processing Group
Conveyor Service and Installation, Inc. - Fort Washington, PA Mar 2012 - May 2012
Service and Installation Technician
From The Head Productions / Armory Films - Los Angeles, CA 2010 - 2011
Craft Service Manager and Production Assistant
Pfizer Oct 2009 - Mar 2010
Research Scientist
Education:
College of Charleston
BS Biochemistry, BA Chemistry Richmond, The American International University in London
Chestnut Hill Academy
Neil Cooch Photo 2

Neil Cooch

View page

Publications

Us Patents

Cancer Vaccines Targeting Boris And Uses Thereof

View page
US Patent:
20210401958, Dec 30, 2021
Filed:
Sep 20, 2021
Appl. No.:
17/479142
Inventors:
- Plymouth Meeting PA, US
Anna SLAGER - Lansdale PA, US
Bradley GARMAN - Glenside PA, US
Neil COOCH - Oreland PA, US
International Classification:
A61K 39/00
Abstract:
Disclosed herein are nucleic acid molecules comprising one or more nucleic acid sequences that encode a synthetic consensus BORIS antigen. Vectors, compositions, and vaccines comprising one or more nucleic acid sequences that encode a synthetic consensus BORIS antigen are disclosed. Methods of treating a subject with a BORIS-expressing tumor and methods of preventing a BORIS-expressing tumor are disclosed. A synthetic consensus BORIS antigen is disclosed.

Cancer Vaccines Targeting Mesothelin And Uses Thereof

View page
US Patent:
20210401959, Dec 30, 2021
Filed:
Sep 7, 2021
Appl. No.:
17/467728
Inventors:
- Plymouth Meeting PA, US
Anna SLAGER - Lansdale PA, US
Bradley GARMAN - Glenside PA, US
Neil COOCH - Oreland PA, US
International Classification:
A61K 39/00
A61K 39/39
A61P 35/00
Abstract:
Disclosed herein are nucleic acid molecules comprising one or more nucleic acid sequences that encode a modified consensus mesothelin antigen. Vectors, compositions, and vaccines comprising one or more nucleic acid sequences that encode a modified consensus mesothelin antigen are disclosed. Methods of treating a subject with a mesothelin-expressing tumor and methods of preventing a mesothelin-expressing tumor are disclosed. Modified consensus mesothelin antigen is disclosed.

Cancer Vaccines Targeting Survivin And Uses Thereof

View page
US Patent:
20190175707, Jun 13, 2019
Filed:
Dec 13, 2018
Appl. No.:
16/219520
Inventors:
- Plymouth Meeting PA, US
Anna SLAGER - Lansdale PA, US
Bradley GARMAN - Glenside PA, US
Neil COOCH - Oreland PA, US
International Classification:
A61K 39/00
C12N 15/62
C12N 15/52
A61P 35/00
A61K 39/39
C07K 16/40
Abstract:
Disclosed herein are nucleic acid molecules comprising one or more nucleic acid sequences that encode synthetic consensus Survivin antigens. Vectors, compositions, and vaccines comprising one or more nucleic acid sequences that encode synthetic consensus Survivin antigens are disclosed. Methods of treating a subject with a Survivin-expressing tumor and methods of preventing a Survivin-expressing tumor are disclosed. Synthetic consensus Survivin antigens are disclosed.

Cancer Vaccines Targeting Muc16 And Uses Thereof

View page
US Patent:
20190175708, Jun 13, 2019
Filed:
Dec 13, 2018
Appl. No.:
16/219460
Inventors:
- Plymouth Meeting PA, US
Anna SLAGER - Lansdale PA, US
Bradley GARMAN - Glenside PA, US
Neil COOCH - Oreland PA, US
International Classification:
A61K 39/00
C07K 14/47
Abstract:
Disclosed herein are nucleic acid molecules comprising one or more nucleic acid sequences that encode a modified consensus MUC16 antigen. Vectors, compositions, and vaccines comprising one or more nucleic acid sequences that encode a modified consensus MUC16 antigen are disclosed. Methods of treating a subject with a MUC16-expressing tumor and methods of preventing a MUC16-expressing tumor are disclosed. Modified consensus MUC16 antigen is disclosed.

Cancer Vaccines Targeting Boris And Uses Thereof

View page
US Patent:
20190175710, Jun 13, 2019
Filed:
Dec 13, 2018
Appl. No.:
16/219268
Inventors:
- Plymouth Meeting PA, US
Anna SLAGER - Lansdale PA, US
Bradley GARMAN - Glenside PA, US
Neil COOCH - Oreland PA, US
International Classification:
A61K 39/00
Abstract:
Disclosed herein are nucleic acid molecules comprising one or more nucleic acid sequences that encode a synthetic consensus BORIS antigen. Vectors, compositions, and vaccines comprising one or more nucleic acid sequences that encode a synthetic consensus BORIS antigen are disclosed. Methods of treating a subject with a BORIS-expressing tumor and methods of preventing a BORIS-expressing tumor are disclosed. A synthetic consensus BORIS antigen is disclosed.

Cancer Vaccines Targeting Mesothelin And Uses Thereof

View page
US Patent:
20190175711, Jun 13, 2019
Filed:
Dec 13, 2018
Appl. No.:
16/219287
Inventors:
- Plymouth Meeting PA, US
Anna SLAGER - Lansdale PA, US
Bradley GARMAN - Glenside PA, US
Neil COOCH - Oreland PA, US
International Classification:
A61K 39/00
A61P 35/00
A61K 39/39
Abstract:
Disclosed herein are nucleic acid molecules comprising one or more nucleic acid sequences that encode a modified consensus mesothelin antigen. Vectors, compositions, and vaccines comprising one or more nucleic acid sequences that encode a modified consensus mesothelin antigen are disclosed. Methods of treating a subject with a mesothelin-expressing tumor and methods of preventing a mesothelin-expressing tumor are disclosed. Modified consensus mesothelin antigen is disclosed.

Cancer Vaccines Targeting Lemd1 And Uses Thereof

View page
US Patent:
20190175712, Jun 13, 2019
Filed:
Dec 13, 2018
Appl. No.:
16/219446
Inventors:
- Plymouth Meeting PA, US
Anna SLAGER - Lansdale PA, US
Bradley GARMAN - Glenside PA, US
Neil COOCH - Oreland PA, US
International Classification:
A61K 39/00
C07K 14/47
Abstract:
Disclosed herein are nucleic acid molecules comprising one or more nucleic acid sequences that encode a mutated consensus LEMD1 antigen. Vectors, compositions, and vaccines comprising one or more nucleic acid sequences that encode a mutated consensus LEMD1 antigen are disclosed. Methods of treating a subject with a LEMD1-expressing tumor and methods of preventing a LEMD1-expressing tumor are disclosed. Mutated consensus LEMD1 antigen is disclosed.

Cancer Vaccines Targeting Prame And Uses Thereof

View page
US Patent:
20190175713, Jun 13, 2019
Filed:
Dec 13, 2018
Appl. No.:
16/219356
Inventors:
- Plymouth Meeting PA, US
Anna SLAGER - Lansdale PA, US
Bradley GARMAN - Glenside PA, US
Neil COOCH - Oreland PA, US
International Classification:
A61K 39/00
C12N 15/62
Abstract:
Disclosed herein are nucleic acid molecules comprising one or more nucleic acid sequences that encode a mutated consensus PRAME antigen. Vectors, compositions, and vaccines comprising one or more nucleic acid sequences that encode a mutated consensus PRAME antigen are disclosed. Methods of treating a subject with a PRAME-expressing tumor and methods of preventing a PRAME-expressing tumor are disclosed. Mutated consensus PRAME antigen is disclosed.
Control profile
Neil S Cooch from Oreland, PA, age ~48 Get Report